Author

Michael Karin

Primary ORCID profile (0000-0002-2758-6473 · 3 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Michael KariniD3 papers · University of California San Diego

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1 Assay:proteomics· 1

Frequent Co-Authors

Alessio LannaiD· 1 shared Clara D’Ambra· 1 shared Federica RinaldiiD· 1 shared Luisa Chocarro· 1 shared Manuel Delpero· 1 shared Melania Capitani· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alessio LannaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Disruptors of sestrin-MAPK interactions rejuvenate T cells and expand TCR specificity

Alessio Lanna, Clara D’Ambra, Federica Rinaldi, Luisa Chocarro, Manuel Delpero, Melania Capitani, Michael Karin

This paper develops DOS, a first-in-class disruptor of sestrin-MAPK complexes, which rejuvenates senescent T cells and expands TCR specificity by generating new T cell clones.

bioRxiv · May 17, 2024 · PreprintImmunology